Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma: results from the DIRECTOR trial

AbstractBackground. The role of reoperation for recurrent glioblastoma (GBM) remains unclear. Prospective studies are lacking. Here, we studied the association

Saved in:

Bibliographic Details
Main Authors:	Suchorska, Bogdana (Author) , Weller, Michael (Author) , Tabatabai, Ghazaleh (Author) , Senft, Christian (Author) , Hau, Peter (Author) , Sabel, Michael C. (Author) , Herrlinger, Ulrich (Author) , Ketter, Ralf (Author) , Schlegel, Uwe (Author) , Marosi, Christine (Author) , Reifenberger, Guido (Author) , Wick, Wolfgang (Author) , Tonn, Jörg C. (Author) , Wirsching, Hans-Georg (Author)
Format:	Article (Journal)
Language:	English
Published:	27 January 2016
In:	Neuro-Oncology Year: 2016, Volume: 18, Issue: 4, Pages: 549-556
ISSN:	1523-5866
DOI:	10.1093/neuonc/nov326
Online Access:	Verlag, Volltext: https://doi.org/10.1093/neuonc/nov326 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/18/4/549/2509360
Author Notes:	Bogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, Christian Senft, Peter Hau, Michael C. Sabel, Ulrich Herrlinger, Ralf Ketter, Uwe Schlegel, Christine Marosi, Guido Reifenberger, Wolfgang Wick, Jörg C. Tonn, and Hans-Georg Wirsching

Description
Summary:	AbstractBackground. The role of reoperation for recurrent glioblastoma (GBM) remains unclear. Prospective studies are lacking. Here, we studied the association
Item Description:	Gesehen am 11.02.2020
Physical Description:	Online Resource
ISSN:	1523-5866
DOI:	10.1093/neuonc/nov326